John Meekin

Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies

Jonathan Rios‐Doria, Jay Harper, Raymond Rothstein et al. · Cancer Research · 2017 · 134 citations

Medicine, Immunology, Pharmacology +17

SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads

Krista Kinneer, John Meekin, Arnaud Tiberghien et al. · Clinical Cancer Research · 2018 · 86 citations

Medicine, Oncology, Pharmacology +17

Resistance to Durvalumab and Durvalumab plus Tremelimumab Is Associated with Functional <i>STK11</i> Mutations in Patients with Non–Small Cell Lung Cancer and Is Reversed by STAT3 Knockdown

Nabendu Pore, Song Wu, Nathan Standifer et al. · Cancer Discovery · 2021 · 82 citations · Full text

Life Sciences, Immunology, Oncology +17

Preclinical assessment of an antibody–PBD conjugate that targets BCMA on multiple myeloma and myeloma progenitor cells

Krista Kinneer, Matt Flynn, Suneetha B. Thomas et al. · Leukemia · 2018 · 61 citations

Pharmacy, Cancer Biology, Oncology +17

Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer

Peter Zanvit, Dewald van Dyk, Christine Fazenbaker et al. · Journal of Clinical Investigation · 2023 · 49 citations · Full text

Life Sciences, Immunology, Oncology +17